Please enable JavaScript.
Coggle requires JavaScript to display documents.
Aspirin - Coggle Diagram
Aspirin
primary prevention
studies
The Antithrombotic Trialists’ (ATT) collaboration primary prevention trials
12 % reduction in serious vascular events (mainly myocardial infarction)
collaborative effort between the ADA, AHA and ACC
nonsignificant reduction in risk of cardiovascular events of 9% (myocardial infarction)
nonsignificant reduction in risk of stroke of 10%
recommendations
women/men ≥50 y
HTN
tobacco use
albuminuria or CKD
family history of early cardiovascular disease
dyslipidemia
without high risk for bleeding
old age
anemia
renal disease
secondary prevention
significant absolute risk reduction in serious vascular events